CH601345A5 - - Google Patents

Info

Publication number
CH601345A5
CH601345A5 CH234275A CH234275A CH601345A5 CH 601345 A5 CH601345 A5 CH 601345A5 CH 234275 A CH234275 A CH 234275A CH 234275 A CH234275 A CH 234275A CH 601345 A5 CH601345 A5 CH 601345A5
Authority
CH
Switzerland
Application number
CH234275A
Inventor
Jean-Claude Dr Hilscher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742409991 external-priority patent/DE2409991C3/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH601345A5 publication Critical patent/CH601345A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CH234275A 1974-02-27 1975-02-25 CH601345A5 (is")

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742409991 DE2409991C3 (de) 1974-02-27 Steroidätherspaltung

Publications (1)

Publication Number Publication Date
CH601345A5 true CH601345A5 (is") 1978-07-14

Family

ID=5908882

Family Applications (1)

Application Number Title Priority Date Filing Date
CH234275A CH601345A5 (is") 1974-02-27 1975-02-25

Country Status (8)

Country Link
US (1) US3956348A (is")
CH (1) CH601345A5 (is")
DD (1) DD116612A5 (is")
DK (1) DK135898C (is")
FR (1) FR2262047B1 (is")
GB (1) GB1502635A (is")
HU (1) HU169938B (is")
NL (1) NL180836C (is")

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5054543A (en) * 1990-01-24 1991-10-08 Chicago Dryer Company Expansion joint for rotary ironers
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US20040214807A1 (en) * 1993-08-06 2004-10-28 D'amato Robert J. Estrogenic compounds as anti-mitotic agents
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US20020002294A1 (en) * 1997-09-24 2002-01-03 D' Amato Robert J. Estrogenic compounds as antiangiogenic agents
EP1124545B1 (en) 1998-08-11 2004-12-15 EntreMed, Inc. Use of 2-methoxyestradiol as anti-fungal agents
US7087592B1 (en) * 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
US6995278B2 (en) * 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US20050192258A1 (en) * 2000-08-18 2005-09-01 Agoston Gregory E. Antiangiogenic agents
WO2003063791A2 (en) * 2002-01-30 2003-08-07 Entremed, Inc. Non-steroidal analogs of 2-methoxyestradiol
CA2527074A1 (en) * 2003-05-28 2005-04-07 Entremed, Inc. Antiangiogenic agents
US20070004689A1 (en) * 2004-03-12 2007-01-04 Agoston Gregory E Antiangiogenic agents
WO2005089256A2 (en) 2004-03-12 2005-09-29 Entremed, Inc. Antiangiogenic agents
US20060116360A1 (en) * 2004-11-29 2006-06-01 Fogler William E Method of administering anti-angiogenic agents and a method of treating disease using same
WO2007059111A2 (en) * 2005-11-14 2007-05-24 Entremed, Inc. Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
US20070176403A1 (en) * 2006-02-01 2007-08-02 Dennis Calderone Air adjustable seat
AU2007227256B2 (en) * 2006-03-20 2012-10-04 Entremed, Inc. Disease modifying anti-arthritic activity of 2-methoxyestradiol
US20080234243A1 (en) * 2007-01-31 2008-09-25 Lavallee Theresa M Method of treating amyloidosis mediated diseases
DE102013203753A1 (de) * 2013-03-05 2014-09-11 Wacker Chemie Ag Verfahren zur Herstellung von Hydroxytyrosol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2140258B1 (is") * 1971-06-07 1974-08-23 Roussel Uclaf
US3845084A (en) * 1973-10-15 1974-10-29 American Home Prod Process for the cleavage of a-ring aromatic,steroidal methyl ethers

Also Published As

Publication number Publication date
DE2409991B2 (de) 1976-01-02
DD116612A5 (is") 1975-12-05
FR2262047B1 (is") 1978-02-24
DK135898C (da) 1977-12-12
NL180836C (nl) 1987-05-04
GB1502635A (en) 1978-03-01
DK135898B (da) 1977-07-11
DK72075A (is") 1975-10-27
NL7502310A (nl) 1975-08-29
DE2409991A1 (de) 1975-09-04
HU169938B (is") 1977-02-28
US3956348A (en) 1976-05-11
FR2262047A1 (is") 1975-09-19

Similar Documents

Publication Publication Date Title
FR2261937B1 (is")
FR2262047B1 (is")
DK126674A (is")
FI751109A7 (is")
FR2258992B1 (is")
CS167093B1 (is")
FI133574A7 (is")
AU6717074A (is")
CS169213B1 (is")
CH576102A5 (is")
BG20647A1 (is")
BG20143A1 (is")
BG19896A1 (is")
BG20001A1 (is")
BG20420A1 (is")
BG19893A1 (is")
DD113596A1 (is")
DD112609A1 (is")
BG20637A1 (is")
DD110471A1 (is")
BG20042A1 (is")
BG20424A1 (is")
CH611912A5 (is")
CH611281A5 (is")
CH600781A5 (is")

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased